Moolec ScienceMLEC -1.04%46 PS Ratio is 0.01 as of Jun. 28, 2026, which is 91% below its 10-year median of 0.11. GuruFocus rates MLEC with a GF Score™ of 46/100 and a GF Value™ of $84.84 (Possible Value Trap). The stock has 9 warning signs investors should review. Among 936 Biotechnology companies, Moolec Science ranks better than 99.89% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Moolec Science's share price is $7.60.
Moolec Science's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $781.24. Hence, Moolec Science's PS Ratio for today is 0.01.
Good Sign:
Moolec Science SA stock PS Ratio (=0.01) is close to 3-year low of 0.01.
The historical rank and industry rank for Moolec Science's PS Ratio or its related term are showing as below:
MLEC'
s PS Ratio Range Over the Past 10 Years
Min: 0.01 Med: 0.11 Max: 0.4
Current: 0.01
During the past 5 years, Moolec Science's highest PS Ratio was 0.40. The lowest was 0.01. And the median was 0.11.
MLEC's PS Ratio is ranked better than 99.89% of 936
companies
in the Biotechnology industry
Industry Median: 9.155
vs MLEC: 0.01
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Moolec Science PS Ratio Related Terms
Moolec Science PS Ratio Historical Data
* Premium members only.
The historical data trend for Moolec Science's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Moolec Science's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Moolec Science PS Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Moolec Science's PS Ratio distribution charts can be found below:
* The bar in red indicates where Moolec Science's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Moolec Science's Share Price of today is $7.60.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Moolec Science's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $781.24.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Moolec Science (MLEC) has a PS Ratio of 0.01 as of Jun. 28, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Moolec Science and its competitors. This is 91% below median its historical median of 0.11. Over the past decade, Moolec Science's PS Ratio has ranged from 0.01 to 0.40. According to the industry distribution chart, Moolec Science ranks #1 out of 936 companies in the Biotechnology industry, placing it in the top 0.099999999999994%.
Is Moolec Science's PS Ratio too high?
Moolec Science's current PS Ratio of 0.01 is 91% below median its 10-year median of 0.11. Over the past 10 years, this metric has ranged from a low of 0.01 to a high of 0.40. The Biotechnology industry median PS Ratio is 9.16. Moolec Science's value of 0.01 is 99.9% below this industry median. Based on the distribution chart, Moolec Science ranks #1 out of 936 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Moolec Science has a GF Score™ of 46/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Moolec Science's PS Ratio compare to RVPH and CDIO?
According to the Biotechnology industry distribution chart, Moolec Science ranks #1 out of 936 companies for PS Ratio. This places Moolec Science in the top 0% of its industry — outperforming the majority of peers. The industry median PS Ratio is 9.16. Moolec Science's value of 0.01 is 99.9% below this benchmark. Historically, Moolec Science's own PS Ratio has ranged from 0.01 to 0.40 over the past decade. While the company's 10-year median is 0.11 vs. the industry median of 9.16, Moolec Science has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Biotechnology company?
The median PS Ratio among Biotechnology companies is 9.16, based on 936 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Moolec Science's current PS Ratio of 0.01 is 99.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Moolec Science and its competitors. For the Biotechnology industry, the median PS Ratio is 9.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Moolec Science's current PS Ratio is 0.01, which is 91% below median its own 10-year median of 0.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Moolec Science stock overvalued right now?
Based on GuruFocus' analysis, Moolec Science (MLEC) is currently considered Possible Value Trap. The stock's GF Value™ is $84.84, compared to a current price of $7.60 — trading 91% below its estimated fair value. The current PS Ratio is 0.01, which is 91% below median its 10-year median of 0.11 and 99.9% below the Biotechnology industry median of 9.16. Moolec Science's overall GF Score™ is 46/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Moolec Science (MLEC), the current PS Ratio is 0.01 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Moolec Science (MLEC) Overvalued in 2026?
Based on GuruFocus' analysis, Moolec Science stock appears to be undervalued.
The current stock price of $7.60 is trading 91% below its estimated GF Value™ of $84.84.
GuruFocus considers Moolec Science to be Possible Value Trap.
Key valuation signals for MLEC:
PS Ratio: 0.01 (91% below median its 10-year median of 0.11)
GF Value™: $84.84 vs. price of $7.60 (91% below fair value)
Industry Position: 99.9% below the Biotechnology median (#1 of 936)
No single metric tells the full story. See the MLEC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline, such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's maximum revenues from operations in Argentina.
46GF Score
Get the complete analysis for MLEC
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MLEC has been successfully added to your 
